# | ||||
---|---|---|---|---|
1 | GOMYTRI Golden Mycological Triangle – joining forces to exploit mycological biodiversity for novel anti-infectives and other beneficial metabolites | 2015 | 333˙000.00 | 333˙000.00 |
2 | IMSTREV Immune modulation by lymph node stromal cell-derived extracellular vesicles | 2015 | 171˙460.00 | 171˙460.00 |
3 | ENLIGHT-TEN European Network linking informatics and genomics of helper T cells | 2015 | 3˙354˙685.00 | 3˙354˙685.00 |
4 | RAPID Rapid Antimicrobial susceptibility testing and phylogenetic Identification | 2016 | 150˙000.00 | 150˙000.00 |
5 | VIVAVE Viral Vaccine Vectors in Personalized Medicine | 2017 | 149˙858.00 | 149˙858.00 |
6 | SWEETBULLETS Sweet Theranostics in Bitter Infections - Seek and Destroy | 2017 | 1˙499˙551.00 | 1˙499˙551.00 |
7 | COMBAT Clearance Of Microbial Biofilms by Advancing diagnostics and Therapy | 2017 | 1˙998˙750.00 | 1˙998˙750.00 |
8 | NOVANI Indentification and optimisation of novel anti-infective agents using multiple hit-identification strategies | 2018 | 1˙499˙367.00 | 1˙499˙367.00 |
9 | NOVINDXS Development of novel inhibitors of the anti-infective target DXS using dynamic combinatorial chemistry (DCC) | 2018 | 171˙460.00 | 171˙460.00 |
10 | MISTRO Identification of the cellular sites of cytomegalovirus latency that contribute to the induction of inflationary CD8 T cell memory against the virus. | 2018 | 159˙460.00 | 159˙460.00 |
11 | CRUZIVAX Vaccine for prevention and treatment of Trypanosoma cruzi infection | 2019 | 0.00 | 8˙391˙240.00 |
12 | INCENTIVE Indo-European Consortium for Next Generation Influenza Vaccine Innovation | 2020 | 19˙965˙992.00 | 9˙974˙293.00 |
13 | CRISPRCOMBO Interrogating native CRISPR arrays to achieve scalable combinatorial screens and dissect genetic redundancy | 2020 | 2˙000˙000.00 | 2˙000˙000.00 |
The Institution HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH has been involved also in the following Horizon 2020 projects.